AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 11 filers reported holding AKARI THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $171 | -6.6% | 1,005 | 0.0% | 0.00% | – |
| Q1 2023 | $183 | -61.2% | 1,005 | 0.0% | 0.00% | – |
| Q4 2022 | $472 | -52.8% | 1,005 | -38.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | -50.0% | 1,621 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 1,621 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | -33.3% | 1,621 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | 0.0% | 1,621 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | -25.0% | 1,621 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | +33.3% | 1,621 | -24.4% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | -25.0% | 2,145 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $4,000 | -33.3% | 2,145 | -41.0% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | -25.0% | 3,633 | -8.1% | 0.00% | -20.0% |
| Q2 2019 | $8,000 | -42.9% | 3,952 | 0.0% | 0.01% | -54.5% |
| Q1 2019 | $14,000 | +27.3% | 3,952 | -4.1% | 0.01% | +120.0% |
| Q3 2018 | $11,000 | – | 4,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |